Yahoo Web Search

Search results

1. • 

     J&J's (JNJ) Q4 Earnings Beat, Darzalex, Stelara Drive Sales

     Zacks via Yahoo Finance· 4 months ago

     Johnson & Johnson’s JNJ fourth-quarter 2023 earnings came in at $2.29 per share, which beat the...

2. • 

     J&J (JNJ) Q4 Earnings Beat, Sales Miss, 2023 EPS View Upbeat

     Zacks via Yahoo Finance· 1 year ago

     J&J (JNJ) beats estimates for fourth-quarter earnings but misses the same for sales. Its EPS outlook...

3. • 

     Strong Q2 at J&J, but outlook cut again due to dollar's rise

     Associated Press via Yahoo News· 2 years ago

     Johnson & Johnson rode sales of the cancer treatment Darzalex and other key drugs to a...

4. • 

     J&J (JNJ) Beats on Q3 Earnings, Cuts 2022 Sales View on Fx Woes

     Zacks via Yahoo Finance· 2 years ago

     Johnson & Johnson’s JNJ third-quarter 2022 earnings came in at $2.55 per share, which beat the Zacks...

5. • 

     Here's The Surprising Driver Of J&J's Second-Quarter Beat, And Why It Didn't Help

     Investor's Business Daily· 2 years ago

     Health care bellwether Johnson & Johnson topped second-quarter expectations Tuesday, but JNJ stock...

6. • 

     Johnson & Johnson (JNJ) Down 2.2% Since Last Earnings Report: Can It Rebound?

     Zacks via Yahoo Finance· 1 year ago

     It has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have...

7. • 

     J&J's cancer drug sales help weather hit from stronger dollar

     Reuters via Yahoo News· 2 years ago

     Johnson & Johnson on Tuesday reported quarterly results that beat analysts' estimates on strong...

8. • 

     J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft

     Zacks via Yahoo Finance· 1 month ago

     Johnson & Johnson’s JNJ first-quarter 2024 earnings came in at $2.71 per share, which beat the Zacks...

9. • 

     Will J&J (JNJ) Pharma Unit Outperform Market & Drive Q1 Results?

     Zacks via Yahoo Finance· 1 year ago

     In J&J's (JNJ) Pharma segment, its oncology drug, Darzalex as well as a psoriasis treatment, Stelara...

10. • 

      Here's Why it is a Good Time to Buy J&J's (JNJ) Stock Now

      Zacks via Yahoo Finance· 9 months ago

      J&J's (JNJ) Pharma sales are being driven by key drugs like Darzalex and new products. J&J's Pharma...